The mechanisms include inhibiting apoptosis by upregulating anti-apoptotic genes such as BCL-2, therefore protecting cancerous cells from programmed cell death and enhancing various transporters and proteins that lead to multidrug resistance in cancer [27,28,29]. This evidence concerns the gene BCL2 and cancer.